logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Keji Pharmaceutical-B (02171.HK) spent 26.3078 million Hong Kong dollars to repurchase 1.734 million shares on November 6th.

date
06/11/2025
The Smart Finance and Economics APP reported that Keji Pharmaceutical-B (02171.HK) announced that it would spend 26.3078 million Hong Kong dollars to repurchase 1.734 million shares on November 6, 2025.
Latest
2 m ago
Federal Reserve Governor Quarles: The Federal Reserve needs to proceed cautiously.
3 m ago
Federal Reserve's Gullsbie: The stable level of interest rates will be significantly lower than the current level. When the situation is uncertain, we should be more cautious and proceed more slowly.
3 m ago
China Medical System (01763.HK): Exhaled diagnosis product wins national pharmaceutical industry single champion.
4 m ago
Federal Reserve's Bullard: The stable level of interest rates will be far lower than the current level. As we approach a critical point in seeing service sector inflation rise, the lack of data is unsettling.
4 m ago
Cloud business rebounds strongly, breaking market doubts! Amazon (AMZN.US) makes a comeback, potentially facing a major reassessment opportunity.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.